0001859061-23-000003.txt : 20230406 0001859061-23-000003.hdr.sgml : 20230406 20230406193122 ACCESSION NUMBER: 0001859061-23-000003 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230406 DATE AS OF CHANGE: 20230406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: A2A Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001859061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40335 FILM NUMBER: 23807486 BUSINESS ADDRESS: STREET 1: 59 5TH AVE CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (914) 841-8818 MAIL ADDRESS: STREET 1: 59 5TH AVE CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biomea Fusion, Inc. CENTRAL INDEX KEY: 0001840439 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 MIDDLEFIELD ROAD STREET 2: 4TH FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: (650) 980-9099 MAIL ADDRESS: STREET 1: 900 MIDDLEFIELD ROAD STREET 2: 4TH FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0407 4/A 2023-03-31 2023-03-31 0 0001840439 Biomea Fusion, Inc. BMEA 0001859061 A2A Pharmaceuticals, Inc. 59 5TH AVE NEW YORK NY 10003 0 0 1 0 0 Common Stock 2023-03-31 4 S 0 200000 31.25 D 4100000 D A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64. Additional details of the individual transactions are available upon request. Edward Painter 2023-04-06